Case File №
#VI-2026-0635
Modern Aminos
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
37 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | E Bad | 4 | 5.8 | 0.0 | 7.9 | 20 Jun 2025 |
| 1-Boc-4-piperidone (tert-butyl 4-oxopiperidine-1-carboxylate) CAS 79099-07-3 | X N/A | 1 | 9.0 | 9.0 | 9.0 | 28 Mar 2025 |
| AA Water | X N/A | 1 | 7.8 | 7.8 | 7.8 | 20 Jun 2025 |
| AHK-CU | X N/A | 1 | 6.0 | 6.0 | 6.0 | 20 Jun 2025 |
| AICAR | X N/A | 1 | 6.1 | 6.1 | 6.1 | 25 Apr 2025 |
| Alprostadil | X N/A | 1 | 4.2 | 4.2 | 4.2 | 13 Jun 2025 |
| Arimidex (Anastrozole) | X N/A | 1 | 7.1 | 7.1 | 7.1 | 9 Jun 2025 |
| BAM15 | X N/A | 1 | 5.9 | 5.9 | 5.9 | 21 May 2025 |
| Blend 500 (Tren E/Mast E) | X N/A | 1 | 5.4 | 5.4 | 5.4 | 13 Jun 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 6.1 | 6.1 | 6.1 | 20 Jun 2025 |
| Cardiogen | X N/A | 1 | 6.4 | 6.4 | 6.4 | 3 Jun 2025 |
| CJC-1295 With DAC | X N/A | 1 | 7.8 | 7.8 | 7.8 | 27 Feb 2025 |
| Clenbuterol | X N/A | 1 | 4.0 | 2.9 | 2.9 | 3 Jun 2025 |
| DHB (1-Test Cyp) Oral | X N/A | 1 | 7.1 | 7.1 | 7.1 | 24 Apr 2025 |
| Epithalon | X N/A | 1 | 7.4 | 7.4 | 7.4 | 28 Mar 2025 |
| Halotestin (Fluoxymesterone) | X N/A | 1 | 4.6 | 4.6 | 4.6 | 2 Jul 2025 |
| HCG | X N/A | 1 | 7.1 | 7.1 | 7.1 | 13 Feb 2025 |
| HGH Fragment 176-191 | X N/A | 1 | 5.7 | 5.7 | 5.7 | 8 Jul 2025 |
| Letrozole | X N/A | 1 | 6.3 | 6.3 | 6.3 | 24 Apr 2025 |
| Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) | X N/A | 1 | 7.6 | 7.6 | 7.6 | 14 Jan 2025 |
| Liraglutide | X N/A | 1 | 4.2 | 4.2 | 4.2 | 8 Jul 2025 |
| Livagen | X N/A | 1 | 6.0 | 6.0 | 6.0 | 3 Jul 2025 |
| Masteron P (Drostanolone P) | X N/A | 1 | 4.0 | 2.7 | 2.7 | 13 Jun 2025 |
| Methylene Blue | X N/A | 1 | 5.0 | 5.0 | 5.0 | 25 Apr 2025 |
| NAD+ | X N/A | 1 | 7.5 | 7.5 | 7.5 | 9 Jun 2025 |
| NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 | X N/A | 1 | 8.7 | 8.7 | 8.7 | 14 Jan 2025 |
| PEG MGF | X N/A | 1 | 4.0 | 3.2 | 3.2 | 28 Mar 2025 |
| Primobolan Oral (Methenolone Acetate) | X N/A | 1 | 7.8 | 7.8 | 7.8 | 8 Jul 2025 |
| Proviron (Mesterolone) | X N/A | 1 | 5.7 | 5.7 | 5.7 | 17 Dec 2024 |
| PTD-DBM | X N/A | 1 | 7.1 | 7.1 | 7.1 | 16 Mar 2025 |
| Retatrutide 5mg + Cagrilintide 5mg Blend | X N/A | 1 | 6.0 | 6.0 | 6.0 | 13 Jun 2025 |
| Semax | X N/A | 1 | 5.6 | 5.6 | 5.6 | 2 Apr 2025 |
| SHRED (L-Carnitine 200mg+B12+B6+Inositol+Methionine+Choline) | X N/A | 1 | 7.7 | 7.7 | 7.7 | 6 May 2025 |
| T3 (Liothyronine) | X N/A | 1 | 6.1 | 6.1 | 6.1 | 20 Jun 2025 |
| Tirzepatide Oral | X N/A | 1 | 7.4 | 7.4 | 7.4 | 25 Apr 2025 |
| Turinabol | X N/A | 1 | 7.4 | 7.4 | 7.4 | 16 Mar 2025 |
| VIP | X N/A | 1 | 4.0 | 3.9 | 3.9 | 8 Jul 2025 |
Exhibit II
Evidence Log
40 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | CJC-1295 With DAC | 6.4 A | 5mg | 4.5mg | -9.2% | 97.67% | xly7mr | Lab E | Public |
| 24 May 2026 | DHB (1-Test Cyp) Oral | 8.3 A | 100mg | 120.9mg | +20.9% | 96.81% | xb1m75 | Lab F | Public |
| 24 May 2026 | NAD+ | 8.2 A | 15mg | 16.1mg | +7.6% | 96.66% | 8991y9 | Lab G | Public |
| 24 May 2026 | BAM15 | 5.2 B | 20mg | 18.6mg | -7.2% | 95.07% | b0obfc | Lab E | Public |
| 24 May 2026 | Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) | 6.2 A | 300mg/ml | 259.8mg/ml | -13.4% | 95.77% | l5kmeo | Lab E | Community |
| 24 May 2026 | SHRED (L-Carnitine 200mg+B12+B6+Inositol+Methionine+Choline) | 8.4 A | 100mg/ml | 101.0mg/ml | +1.0% | 98.56% | axawsf | Lab E | Public |
| 24 May 2026 | HGH Fragment 176-191 | 8.7 A | 10mg | 11.2mg | +12.1% | 96.93% | 3rhl15 | Lab E | Community |
| 24 May 2026 | Tirzepatide Oral | 6.5 A | 100mg | 96.5mg | -3.5% | 97.27% | tamqkm | Lab G | Public |
| 23 May 2026 | Arimidex (Anastrozole) | 7.9 A | 100mg | 93.3mg | -6.7% | 99.74% | 2x7d60 | Lab E | Public |
| 23 May 2026 | Semax | 5.1 B | 2mg | 1.9mg | -4.7% | 96.88% | zzvom0 | Lab F | Public |
| 21 May 2026 | AICAR | 7.2 A | 20mg | 19.6mg | -2.0% | 99.24% | wx3lb1 | Lab D | Public |
| 21 May 2026 | Masteron P (Drostanolone P) | 4.7 C | 300mg/ml | 274.7mg/ml | -8.4% | 97.07% | 82zh11 | Lab G | Community |
| 21 May 2026 | PEG MGF | 4.0 C | 30mg | 28.1mg | -6.4% | 96.90% | zfjaj7 | Lab B | Public |
| 17 May 2026 | BPC157 5mg + TB500 5mg Blend | 5.9 B | 2mg | 2.1mg | +4.4% | 96.68% | lbxfsh | Lab G | Community |
| 29 Jan 2026 | Livagen | 4.0 C | 20mg | 21.6mg | +8.2% | 96.41% | nf81cc | Lab G | Public |
| 26 Jan 2026 | NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 | 9.1 A | 5g | 4.9g | -1.6% | 96.57% | t5k128 | Lab E | Public |
| 9 Jan 2026 | VIP | 4.0 C | 15mg | 13.4mg | -10.4% | 97.04% | aodwja | Lab C | Public |
| 7 Jan 2026 | HCG | 5.4 B | 20mg | 21.1mg | +5.6% | 95.77% | asamnr | Lab C | Public |
| 29 Dec 2025 | Clenbuterol | 4.7 C | 100mg | 88.2mg | -11.8% | 95.96% | 82cf5b | Lab C | Community |
| 29 Dec 2025 | Proviron (Mesterolone) | 5.6 B | 25mg | 30.5mg | +21.9% | 97.98% | isoa9a | Lab E | Public |
| 12 Dec 2025 | AA Water | 9.5 A | 20mg | 24.6mg | +23.1% | 96.22% | 7npz3e | Lab F | Public |
| 5 Dec 2025 | Retatrutide 5mg + Cagrilintide 5mg Blend | 5.1 B | 5mg | 5.3mg | +7.0% | 97.84% | naprka | Lab F | Public |
| 17 Nov 2025 | AHK-CU | 5.3 B | 20mg | 23.2mg | +15.8% | 97.38% | rx7wki | Lab F | Community |
| 17 Nov 2025 | Cardiogen | 5.3 B | 30mg | 35.2mg | +17.2% | 99.91% | a3bnur | Lab E | Public |
| 17 Nov 2025 | Letrozole | 5.1 B | 100mg | 124.4mg | +24.4% | 96.06% | pqcy2f | Lab A | Community |
| 17 Nov 2025 | Primobolan Oral (Methenolone Acetate) | 9.9 A | 10mg | 10.2mg | +2.0% | 98.28% | xdawd3 | Lab E | Public |
| 14 Nov 2025 | Epithalon | 6.7 A | 5mg | 5.2mg | +3.7% | 98.68% | 0hfujy | Lab F | Community |
| 5 Nov 2025 | Turinabol | 7.3 A | 25mg | 26.9mg | +7.8% | 96.20% | srj280 | Lab E | Community |
| 4 Nov 2025 | Liraglutide | 4.0 C | 20mg | 23.4mg | +17.1% | 97.44% | v5gihd | Lab F | Public |
| 4 Nov 2025 | Methylene Blue | 5.9 B | 25mg | 30.9mg | +23.6% | 99.76% | paqmu4 | Lab F | Public |
| 4 Nov 2025 | T3 (Liothyronine) | 7.1 A | 25mg | 25.9mg | +3.7% | 96.31% | zaw0p1 | Lab E | Public |
| 17 Oct 2025 | 1-Boc-4-piperidone (tert-butyl 4-oxopiperidine-1-carboxylate) CAS 79099-07-3 | 8.6 A | 5g | 4.8g | -3.1% | 97.33% | b6limx | Lab C | Public |
| 9 Oct 2025 | Alprostadil | 4.0 C | 20mg | 19.1mg | -4.4% | 98.05% | pfdueo | Lab D | Community |
| 9 Oct 2025 | Blend 500 (Tren E/Mast E) | 5.8 B | 300mg/ml | 279.9mg/ml | -6.7% | 96.83% | bkf4a4 | Lab E | Community |
| 9 Oct 2025 | Halotestin (Fluoxymesterone) | 5.6 B | 20mg | 18.7mg | -6.5% | 97.29% | g6j03a | Lab G | Public |
| 9 Oct 2025 | PTD-DBM | 8.2 A | 5mg | 4.7mg | -6.5% | 95.95% | snbjow | Lab C | Public |
| 5 Oct 2025 | Retatrutide | 7.9 A | 10mg | 9.62mg | -3.8% | 99.85% | (no batch ID) | Lab E | Public |
| 4 Sep 2025 | Retatrutide | 7.9 A | 10mg | 10mg | 99.85% | (no batch ID) | Lab E | Public | |
| 9 Jul 2025 | Retatrutide | 0.0 E | 10mg | ⚠️ Sample does not contain Retatrutide ? | (no batch ID) | No Label / Silver Crimp / White Cap | Lab A | — | — |
| 20 Jun 2025 | Retatrutide | 7.6 A | 10mg | 9.85mg | -1.5% | 99.75% | (no batch ID) | Lab E | Public |
— END OF EVIDENCE LOG —